Molecular Diagnostic Instrumentation, Country Market Shares, Strategic Profiles of Leading Suppliers, 2019
This 103-page report is designed to help suppliers identify and evaluate emerging opportunities for further automating NAT methods in order to facilitate their penetration into the routine clinical laboratory market. Some instrumentation is already available on the market, e.g., DNA extractors, DNA synthesizers, thermal cyclers, robotic work-stations, and automated DNA probe analysis systems. The report reviews current instrumentation technologies, and compares features of leading molecular diagnostics analyzers marketed by Abbott, Beckman Coulter, BD, Bio-Rad, Gen-Probe, Tecan, Trinity Biotech and other manufacturers.
This report also presents strategic assessments of current and emerging suppliers of NAT products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Instrumentation Review
1. Abbott LCx
2. Beckman Coulter/Biomek FK
3. Becton Dickinson SDA
4. Bio-Rad GeneScope
5. Gen-Probe Tigris
6. Roche Cobas Amplicor
7. Tecan LS Series
Competitive Profiles
- Abbott
- Affymetrix
- Agilent Technlogies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- BioMerieux
- Bio-Rad Laboratories
- Biotest
- Cepheid
- CellMark Forensics/LabCorp
- Decode Genetics
- Diadexus
- Eiken
- Elitech Group
- Enzo
- Exact Sciences
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- Illumina
- Kreatech/Leica
- Li-Cor Biosciences
- Monogram Biosciences
- Ortho-Clinical Diagnostics
- Perkin Elmer Caliper
- Proteome Sciences
- Qiagen
- Roche
- Scienion
- Sequenom
- Shimadzu
- Siemens
- Sierra Molecular
- Takara Bio
- Tecan Group
- Thermo Fisher
2020 Winning Strategies in Molecular Diagnostics: US, Europe, Japan--Integrating New Technology Planning with Business Strategies--Country Shares and Market Segment Forecasts for 100 Tests--Technological Breakthroughs, Emerging Tests, Competitive Intelligence
This new seven-country study contains 1,050 pages, 96 tables, and is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular
View Report2020 U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies
The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.This new study contains 430 pages, and is designed to help current
View Report2020 Winning Strategies in Molecular Diagnostics: US, Europe, Japan--Integrating New Technology Planning with Business Strategies--Country Shares and Market Segment Forecasts for 100 Tests--Technological Breakthroughs, Emerging Tests, Competitive Intelligence
This new seven-country study contains 1,050 pages, 96 tables, and is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular
View Report2020 U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies
The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.This new study contains 430 pages, and is designed to help current
View ReportFill The Form For Sample Request